Private organizations not affiliated with the United States
Patent and Trademark Office (USPTO) often use the USPTO's
publicly available trademark database to obtain applicant
information, and then disseminate deceptive, official-looking
invoices for fees due in connection with US trademark applications
and registrations. These organizations use official-sounding names
such as the "United States Trademark Registration Office"
and the "Worldwide Database of Trademarks and Patents."
The invoices often mimic official government correspondence, refer
to other governmental organizations, and emphasize official
information such as registration numbers, application numbers, and
These "invoices" are merely solicitations for
unnecessary services, such as registration of trademarks in a
private registry, or services that may already be performed by
reputable vendors, such as trademark monitoring services. Close
examination of the solicitations typically reveal that there is no
obligation to pay.
When a trademark applicant is represented by an attorney, the
USPTO will correspond directly with the attorney of record and will
not send correspondence directly to the applicant. All USPTO
correspondence comes from either a proper "uspto.gov"
email address or a mailing address in Alexandria, VA.
You can safely ignore trademark solicitations from organizations
not affiliated with the United States Patent and Trademark Office.
Consult your trademark attorney if you are unsure about a specific
In Wasica Finance GmbH v. Continental Automotive Systems, Inc., No. 15-2078 (Fed. Cir. 2017), the patentee Wasica Finance discovered, among other things, the importance of using consistent terminology in the patent specification and claims.
While under attack for several years now, the patent infringement defense of laches was dealt a serious, and likely final, blow by the recent Supreme Court case of SCA Hygiene Products AB et al. v. First Quality Baby Products LLC et al.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
On April 6, 2017, the Federal Circuit reversed-in-part and affirmed-in-part the district court's judgment of infringement and summary judgment for non-infringement of The Medicines Company's ("MedCo") patents-in-suit.
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).